FDA.reportPublic FDA data

POLYETHYLENE GLYCOL 6000

Substance profile for UNII 30IQX730WE, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
30IQX730WE
Preferred term
POLYETHYLENE GLYCOL 6000
Registry number
25322-68-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1314384
PubChem
0
NCIt
C84085
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1314384mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1314384
NCI ThesaurusC84085ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C84085
FDA Substance Registration System30IQX730WEprecision.fda.gov/uniisearch/srs/unii/30IQX730WE

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
AMOXICILLIN AND CLAVULANATE POTASSIUM1
These highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN tablets, for oral use Initial U.S. Approval: 19968
These highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets . Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 19921
NABUMETONE2
These highlights do not include all the information needed to use donepezil hydrochloride tablets safely and effectively. See full prescribing information for donepezil hydrochloride tablets. Donepezil Hydrochloride Tablets USP, for oral use Rx Only Initial U.S. Approval: 19967
Rx only4
These highlights do not include all the information needed to use Escitalopram Tablets USP safely and effectively. See full prescribing information for Escitalopram Tablets USP. Initial U.S. Approval: 20023
Morphine Sulfate Extended-release Capsules, USP Revised: May 2011 CII Rx only 1985282
Rx only2
Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP1
Metformin Hydrochloride Tablets USP1
Zinc Oxide Ointment7
These highlights do not include all the information needed to use clopidogrel bisulfate safely and effectively. See full prescribing information for clopidogrel tablets, USP. CLOPIDOGREL Tablets USP, for oral use Initial U.S. Approval: 19974
Zinc Oxide Ointment12
These highlights do not include all the information needed to use donepezil hydrochloride safely and effectively. See full prescribing information for donepezil hydrochloride tablets. Donepezil hydrochloride tablets USP, film coated for oral use Initial U.S. Approval: 19961
These highlights do not include all the information needed to use Escitalopram Tablets USP safely and effectively. See full prescribing information for Escitalopram Tablets USP. Initial U.S. Approval: 20025
Metformin Hydrochloride Tablets, USP2
Paroxetine Tablets, USP1
These highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets . Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 19921
These highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets. Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 19923
Paroxetine19
These highlights do not include all the information needed to use clopidogrel bisulfate safely and effectively. See full prescribing information for clopidogrel tablets, USP. CLOPIDOGREL Tablets USP, for oral use Initial U.S. Approval: 19971
Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP2
FACTIVE ® (gemifloxacin mesylate) Tablets1
Paroxetine Tablets, USP1
These highlights do not include all the information needed to use VALACYCLOVIR tablets, USP safely and effectively. See full prescribing information for VALACYCLOVIR tablets, USP. VALACYCLOVIR tablets, USP, for oral use Initial U.S. Approval: 19951
These highlights do not include all the information needed to use clopidogrel bisulfate safely and effectively. See full prescribing information for clopidogrel tablets, USP. Clopidogrel Tablets, USP Initial U.S. Approval: 19971
SohMed™ Pain Relief PM1
SohMed™ Sinus1
SohMed™ Allergy1
SohMed™ Cold Relief1
SohMed™ Allergy Sinus1
SohMed™ Extra Strength1
Galshield Zinc Oxide / Dimethicone1
Galentic GalShield Ointment1
Drug Facts4
These highlights do not include all the information needed to use metoprolol succinate extended-release tablets safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets. Metoprolol Succinate Extended-Release Tablets, USP for Oral Use INITIAL U.S. APPROVAL: 19925
Drug Facts1
Drug Facts1
ConRx™ Allergy Sinus1
ConRx™ Cold1
ConRx™ Alert1
ConRx™ Allergy1
ConRx™ Extra Strength1
ConRx™ pain Reliever1
ConRx™ PM1
ConRx™ Sinus1
f3c500b9-1fdd-4382-921d-b333d92d34e72
These highlights do not include all the information needed to use clopidogrel safely and effectively. See full prescribing information for clopidogrel. Clopidogrel Tablets, USP Initial U.S. Approval: 19972
Paroxetine Tablets, USP1
4aad770b-a342-45c5-8199-21a1240603141
ConRx Allergy Sinus Multi-Symptoms1
ConRx Cold1
ConRx Sinus1
These highlights do not include all the information needed to use lansoprazole safely and effectively. See full prescribing information for: Lansoprazole Delayed-Release Capsules, USP For oral administration Initial U.S. Approval: 19951
These highlights do not include all the information needed to use KEPPRA ® safely and effectively. See full prescribing information for KEPPRA. KEPPRA (levetiracetam) tablets, for oral use KEPPRA (levetiracetam) oral solution Initial U.S. Approval: 19993
Glytone Essentials rejuvenate daily3
These highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 20012
ATOPALM Oral Pain Relief Gel1
These highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX. PLAVIX (clopidogrel bisulfate) tablets Initial U.S. Approval: 19973
These highlights do not include all the information needed to use donepezil hydrochloride tablets safely and effectively. See full prescribing information for donepezil hydrochloride tablets. Donepezil Hydrochloride Tablets Rx Only Initial U.S. Approval: 19961
b4db7cdc-bcad-4825-9840-6c36246c6d314
Bisoprolol Fumarate Tablets USP2
Prilosec OTC ® omeprazole magnesium delayed- release tablets 20.6 mg / acid reducer1
These highlights do not include all the information needed to use Fenoglide ® safely and effectively. See full prescribing information for Fenoglide. Fenoglide (fenofibrate) Tablets Initial U.S. Approval: 19932
7b1d9124-5fde-4f57-9fca-ee061750fcc31
Drug Fact1
OCELLA ™ 28 TABLETS (drospirenone and ethinyl estradiol)2
Glytone Retexturize Body2
Drug Facts1
These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets, USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets, USP. Pantoprazole Sodium Delayed-Release Tablets, USP Initial U.S. approval: 20002
Paroxetine Tablets, USP1
KEPPRA ® (levetiracetam) 250 mg, 500 mg, 750 mg, and 1000 mg tablets 100 mg/mL oral solution1
These highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX. PLAVIX (clopidogrel bisulfate) tablets Initial U.S. Approval: 19971
Bisoprolol Fumarate Tablets USP1
These highlights do not include all the information needed to use BONIVA Tablets safely and effectively. See full prescribing information for BONIVA Tablets. BONIVA® (ibandronate sodium) Tablets Initial U.S. Approval: 20031
These highlights do not include all the information needed to use Natazia safely and effectively. See full prescribing information for Natazia. Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for oral use Initial U.S. Approval: 20101
These highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX. PLAVIX (clopidogrel bisulfate) tablets Initial U.S. Approval: 19972
PAROXETINE TABLETS USP1
Metformin Hydrochloride Tablets USP4
Metformin Hydrochloride Tablets, USP1
These highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX. PLAVIX (clopidogrel bisulfate) tablets Initial U.S. Approval: 19971
These highlights do not include all the information needed to use FENOGLIDE safely and effectively. See full prescribing information for FENOGLIDE. FENOGLIDE (fenofibrate) tablet for oral use Initial U.S. Approval: 19931
BUPROPION HYDROCHLORIDE TABLETS USP Rx only1
f0b31daa-0792-43d5-af08-8b6a864dc90a1
89245260-c470-4a4c-8ef6-12598dc28e4c2
PAROXETINE (PAROXETINE HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3988
PLAVIX (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3378
METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3282
PAROXETINE (PAROXETINE HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3198
ONDANSETRON HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3071
ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]1002
ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
BISOPROLOL FUMARATE TABLET [BRYANT RANCH PREPACK]1000
BUPROPION HYDROCHLORIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
FINASTERIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
VALACYCLOVIR TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
MIRTAZAPINE TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]379
PAROXETINE (PAROXETINE HYDROCHLORIDE) TABLET [INTERNATIONAL LABORATORIES, INC.]27
LIALDA (MESALAMINE) TABLET, DELAYED RELEASE [SHIRE US MANUFACTURING INC.]26
BONIVA (IBANDRONATE SODIUM) TABLET, FILM COATED [GENENTECH, INC.]22
MULTAQ (DRONEDARONE) TABLET, FILM COATED [SANOFI-AVENTIS U.S. LLC]22
PLAVIX (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [BRISTOL-MYERS SQUIBB/SANOFI PHARMACEUTICALS PARTNERSHIP]20
KEPPRA (LEVETIRACETAM) TABLET, FILM COATED KEPPRA (LEVETIRACETAM) SOLUTION [UCB, INC.]16
DYNASHIELD WITH DIMETHICONE (ZINC OXIDE AND DIMETHICONE) CREAM [DYNAREX CORPORATION]14
FAMCICLOVIR TABLET, FILM COATED [ACTAVIS PHARMA, INC.]14
KEPPRA XR (LEVETIRACETAM) TABLET, FILM COATED, EXTENDED RELEASE [UCB, INC.]14
PAROXETINE (PAROXETINE HYDROCHLORIDE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]14
TOPIRAMATE CAPSULE, COATED PELLETS [TEVA PHARMACEUTICALS USA INC]14
FINASTERIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]13
MIRTAZAPINE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]13
AROMASIN (EXEMESTANE) TABLET [PHARMACIA AND UPJOHN COMPANY]12
ESCITALOPRAM TABLET, FILM COATED [INTERNATIONAL LABS, INC.]12
ONDANSETRON HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]12
VALACYCLOVIR TABLET, FILM COATED [RANBAXY PHARMACEUTICALS INC.]12
DOXYCYCLINE TABLET [HERITAGE PHARMACEUTICALS INC.]11
METFORMIN HYDROCHLORIDE TABLET, FILM COATED [ASCEND LABORATORIES, LLC]11
ULTRAMICROSIZE GRISEOFULVIN (ULTRAMICROSIZE GRISEOFULVIN TABLETS) TABLET, COATED [COREPHARMA, LLC]11
DESVENLAFAXINE TABLET, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]10

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 30IQX730WE page 1 of 1 · 15 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
POLYETHYLENE GLYCOL 600030IQX730WE25322683TABLETBUCCAL70 mg
POLYETHYLENE GLYCOL 600030IQX730WE25322683CAPSULEORAL3700 mg
POLYETHYLENE GLYCOL 600030IQX730WE25322683CAPSULE, DELAYED RELEASEORAL35 mg
POLYETHYLENE GLYCOL 600030IQX730WE25322683CAPSULE, DELAYED RELEASE PELLETSORAL135 mg
POLYETHYLENE GLYCOL 600030IQX730WE25322683CAPSULE, EXTENDED RELEASEORAL302 mg
POLYETHYLENE GLYCOL 600030IQX730WE25322683TABLETORAL750 mg
POLYETHYLENE GLYCOL 600030IQX730WE25322683TABLET, COATEDORAL106 mg
POLYETHYLENE GLYCOL 600030IQX730WE25322683TABLET, DELAYED RELEASEORAL120 mg
POLYETHYLENE GLYCOL 600030IQX730WE25322683TABLET, EXTENDED RELEASEORAL250 mg
POLYETHYLENE GLYCOL 600030IQX730WE25322683TABLET, FILM COATEDORAL132 mg
POLYETHYLENE GLYCOL 600030IQX730WE25322683TABLET, ORALLY DISINTEGRATING, DELAYED RELEASEORAL69 mg
POLYETHYLENE GLYCOL 600030IQX730WE25322683SUPPOSITORYRECTAL128 mg
POLYETHYLENE GLYCOL 600030IQX730WE25322683TABLETSUBLINGUAL70 mg
POLYETHYLENE GLYCOL 600030IQX730WE25322683CREAMTOPICAL5 %w/w
POLYETHYLENE GLYCOL 600030IQX730WE25322683INSERTVAGINAL0.06 mg